Related Experiment Video
Updated: Jun 7, 2026

06:46
Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection
Published on: January 9, 2026
Surgery for colonic cancer in HNPCC: total vs segmental colectomy
D A Stupart1, P A Goldberg, R J Baigrie
1Colorectal Unit, Department of Surgery, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa. DouglasStupart@yahoo.co.uk
Summary
Patients with hereditary nonpolyposis colorectal cancer (HNPCC) undergoing segmental colectomy face a significant risk of metachronous colon cancer (MCC). Total colectomy eliminates this risk, improving cancer-specific survival.
Area of Science:
- Oncology
- Gastroenterology
- Surgical Oncology
Background:
- Hereditary nonpolyposis colorectal cancer (HNPCC) patients have a high risk of metachronous colon cancer (MCC).
- Total colectomy (TC) is debated as the preferred surgery for primary colon cancer in HNPCC due to MCC risk.
- No prior studies compared survival after TC versus segmental colectomy (SC) in HNPCC.
Purpose of the Study:
- To assess MCC risk in HNPCC patients after SC versus TC.
- To compare long-term survival outcomes between SC and TC in HNPCC patients.
Main Methods:
- Prospective cohort study of 60 HNPCC patients with proven germline mismatch repair gene defects (1995-2009).
- Patients underwent either SC or TC for colon adenocarcinoma with curative intent.
- Annual endoscopic surveillance was offered to all participants.
Main Results:
- After a median follow-up of 6 years, MCC developed in 8 of 21 (38%) SC patients versus none of 39 TC patients (P=0.048).
- The 5-year risk of MCC after SC was 20%.
- Colorectal cancer-specific survival was significantly better in the TC group (P=0.048), though overall survival was similar (P=0.29).
Conclusions:
- HNPCC patients face a substantial risk of developing metachronous colon cancer following SC.
- Total colectomy as the primary surgical approach for colon cancer in HNPCC patients effectively eliminates the risk of MCC.

